Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer
14 ビュー
• 07/14/23
0
0
埋め込む
administrator
加入者
David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).
More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance
もっと見せる
フェイスブックのコメント
SORT BY-
トップコメント
-
最新のコメント